Skip to main content

Clinical and Pre-clinical Methods for Quantifying Tumor Hypoxia.

Publication ,  Journal Article
Rickard, AG; Palmer, GM; Dewhirst, MW
Published in: Adv Exp Med Biol
2019

Hypoxia, a prevalent characteristic of most solid malignant tumors, contributes to diminished therapeutic responses and more aggressive phenotypes. The term hypoxia has two definitions. One definition would be a physiologic state where the oxygen partial pressure is below the normal physiologic range. For most normal tissues, the normal physiologic range is between 10 and 20 mmHg. Hypoxic regions develop when there is an imbalance between oxygen supply and demand. The impact of hypoxia on cancer therapeutics is significant: hypoxic tissue is 3× less radiosensitive than normoxic tissue, the impaired blood flow found in hypoxic tumor regions influences chemotherapy delivery, and the immune system is dependent on oxygen for functionality. Despite the clinical implications of hypoxia, there is not a universal, ideal method for quantifying hypoxia, particularly cycling hypoxia because of its complexity and heterogeneity across tumor types and individuals. Most standard imaging techniques can be modified and applied to measuring hypoxia and quantifying its effects; however, the benefits and challenges of each imaging modality makes imaging hypoxia case-dependent. In this chapter, a comprehensive overview of the preclinical and clinical methods for quantifying hypoxia is presented along with the advantages and disadvantages of each.

Duke Scholars

Published In

Adv Exp Med Biol

DOI

ISSN

0065-2598

Publication Date

2019

Volume

1136

Start / End Page

19 / 41

Location

United States

Related Subject Headings

  • Tumor Hypoxia
  • Oxygen
  • Neoplasms
  • Humans
  • General & Internal Medicine
  • Cell Hypoxia
  • 32 Biomedical and clinical sciences
  • 31 Biological sciences
  • 11 Medical and Health Sciences
 

Citation

APA
Chicago
ICMJE
MLA
NLM
Rickard, A. G., Palmer, G. M., & Dewhirst, M. W. (2019). Clinical and Pre-clinical Methods for Quantifying Tumor Hypoxia. Adv Exp Med Biol, 1136, 19–41. https://doi.org/10.1007/978-3-030-12734-3_2
Rickard, Ashlyn G., Gregory M. Palmer, and Mark W. Dewhirst. “Clinical and Pre-clinical Methods for Quantifying Tumor Hypoxia.Adv Exp Med Biol 1136 (2019): 19–41. https://doi.org/10.1007/978-3-030-12734-3_2.
Rickard AG, Palmer GM, Dewhirst MW. Clinical and Pre-clinical Methods for Quantifying Tumor Hypoxia. Adv Exp Med Biol. 2019;1136:19–41.
Rickard, Ashlyn G., et al. “Clinical and Pre-clinical Methods for Quantifying Tumor Hypoxia.Adv Exp Med Biol, vol. 1136, 2019, pp. 19–41. Pubmed, doi:10.1007/978-3-030-12734-3_2.
Rickard AG, Palmer GM, Dewhirst MW. Clinical and Pre-clinical Methods for Quantifying Tumor Hypoxia. Adv Exp Med Biol. 2019;1136:19–41.

Published In

Adv Exp Med Biol

DOI

ISSN

0065-2598

Publication Date

2019

Volume

1136

Start / End Page

19 / 41

Location

United States

Related Subject Headings

  • Tumor Hypoxia
  • Oxygen
  • Neoplasms
  • Humans
  • General & Internal Medicine
  • Cell Hypoxia
  • 32 Biomedical and clinical sciences
  • 31 Biological sciences
  • 11 Medical and Health Sciences